about
MiR-155 up-regulated by TGF-β promotes epithelial-mesenchymal transition, invasion and metastasis of human hepatocellular carcinoma cells in vitro.The transcription factor GLI1 mediates TGFβ1 driven EMT in hepatocellular carcinoma via a SNAI1-dependent mechanism.MRC-5 fibroblast-conditioned medium influences multiple pathways regulating invasion, migration, proliferation, and apoptosis in hepatocellular carcinoma.Huaier restrains proliferative and invasive potential of human hepatoma SKHEP-1 cells partially through decreased Lamin B1 and elevated NOV.Epithelial-mesenchymal transition in hepatocellular carcinoma.HOXB9 promotes epithelial-to-mesenchymal transition via transforming growth factor-β1 pathway in hepatocellular carcinoma cells.PDGF enhances IRES-mediated translation of Laminin B1 by cytoplasmic accumulation of La during epithelial to mesenchymal transition.Long non-coding RNA CARLo-5 promotes tumor progression in hepatocellular carcinoma via suppressing miR-200b expression.Important and relevant symptoms including pain concerns in hepatocellular carcinoma (HCC): a patient interview study.Ezrin as a possible diagnostic and/or prognostic biomarker in mice lymphatic metastatic hepatocellular carcinoma in vivo.Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma.Integrating the patient voice with clinician reports to identify a hepatocellular carcinoma-specific subset of treatment-related symptomatic adverse events
P2860
Q33850292-CB46B28D-1BCA-456D-ADA4-56891A57F8DDQ34490202-878FC98C-4989-4874-88E2-A0990C7F5459Q35869684-DD050A9F-95F3-4E92-BD81-86EB3D9D1C86Q37159921-D30BD734-6646-4108-B045-A4F6A6905921Q37620382-E005B21B-E8D3-4B07-8D1E-90733983AAD3Q38969822-156DC90A-55F4-4811-86F9-4C718BB3F0DAQ42213394-2B47291A-79F5-4D73-91D2-B8D139F3A072Q42378415-0A53369C-8E1F-42FA-9130-9BD10B523E5DQ48131474-C009E08B-695D-4EC0-9581-31E7F7EC6A4EQ48285997-171211F1-F46A-4B12-AC99-EF8C02797D57Q52586706-D140BB21-63CD-4A91-BC8D-B895FBF7964DQ57213665-678E97CC-ED8B-4BB7-A7EE-18102C476A80
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Symptom management in hepatocellular carcinoma
@ast
Symptom management in hepatocellular carcinoma
@en
type
label
Symptom management in hepatocellular carcinoma
@ast
Symptom management in hepatocellular carcinoma
@en
prefLabel
Symptom management in hepatocellular carcinoma
@ast
Symptom management in hepatocellular carcinoma
@en
P2860
P356
P1476
Symptom management in hepatocellular carcinoma
@en
P2093
Linda Sarna
P2860
P304
P356
10.1188/08.CJON.759-766
P577
2008-10-01T00:00:00Z